Process for dealing with sexual misconduct by doctors requires major reform

Sanctions are inconsistent and overly reliant on subjective evidence, say experts The current process for managing sexual misconduct perpetrated by doctors in the UK requires major reform, say experts in The BMJ today. Mei Nortley and colleagues argue that sanctioning of doctors is inconsistent and overly reliant on subjective evidence and they ...

2025-09-22T13:56:28+01:0019 September 2025|Press release, The BMJ|

Risk of a second cancer after early breast cancer is low

Findings are reassuring for patients and should be shared widely For women diagnosed with early breast cancer, the long-term risk of developing a second primary cancer is low (around 2-3% greater than women in the general population), finds a study published by The BMJ today. The researchers say this information can help ...

2025-08-28T08:47:44+01:0028 August 2025|Press release, The BMJ|

Menopause misinformation is harming care, warn experts

Commercial hormone testing is unnecessary and does not improve care Symptoms should be prioritised ahead of testing Many direct to consumer menopause services are unnecessary and do not improve care, warn experts in The BMJ today. They argue that the sharp rise in commercial services for women seeking relief for menopausal symptoms ...

2025-08-26T10:27:43+01:0026 August 2025|Press release, The BMJ|

Companies may be misleading parents with “outrageous claims” about banking baby teeth

Experts alarmed by “outrageous” treatment claims for autism and diabetes Several claims to be reviewed by Advertising Standards Agency Parents are spending thousands of pounds to bank stem cells from their children’s milk teeth – but the recipient companies’ claims about their future medical value are unproven and potentially misleading, ...

2025-08-26T10:24:27+01:0026 August 2025|Press release, The BMJ|

Experts recommend SGLT-2 and GLP-1 diabetes drugs only for adults at moderate to higher risk of heart and kidney problems

Recommendations account for varied patient risk profiles and focus on weight loss effects, particularly of drugs of interest to adults with concomitant obesity SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and kidney ...

2025-08-15T14:49:00+01:0015 August 2025|Press release, The BMJ|
Go to Top